Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.60
-0.1500-4.00%
Pre-market: 3.670.0695+1.93%08:50 EDT
Volume:16.38M
Turnover:60.51M
Market Cap:1.90B
PE:-2.50
High:3.90
Open:3.85
Low:3.53
Close:3.75
52wk High:7.18
52wk Low:2.80
Shares:527.40M
Float Shares:415.00M
Volume Ratio:1.70
T/O Rate:3.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4410
EPS(LYR):-1.4410
ROE:-59.54%
ROA:-27.72%
PB:1.68
PE(LYR):-2.50

Loading ...

Apr 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 25, 2026

Major Issues Report

Form 8-K - Current report
Mar 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS Director Borgeson Blake proposes to sell 170,000 shares, with a total value of approximately $588,200.
Feb 25, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 25, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2026

Major Issues Report

Form 8-K - Current report
Feb 19, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Director Christopher Gibson proposes to sell 40,000 shares, with a total value of approximately $138,400
Feb 18, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Taylor Ben R proposes to sell 13426 shares, with a total value of approximately $41352.08.
Feb 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 20, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Director Christopher Gibson proposes to sell 40,000 shares, with a total value of approximately $178,800
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 06, 2026

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS' Director B. Borgeson proposes to sell 220,000 shares, with a total value of approximately $959.2K.
Jan 05, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Director Gibson Christopher proposes to sell 40,000 Shares, with a total value of approximately $170,000.
Dec 29, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Taylor Ben R proposes to sell 21,383 shares, with a total value of approximately $89K.
Dec 22, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Najat Khan proposes to sell 124,403 Shares, with a total value of approximately $548,587.96